Development of a transplantable glioma tumour model from genetically engineered mice: MRI/MRS/MRSI characterisation (Q48665122)

14 February 2018

title

Development of a transplantable glioma tumour model from genetically engineered mice: MRI/MRS/MRSI characterisation (English)

1 reference

14 February 2018

1 reference

14 February 2018

Carles Arús

1 reference

14 February 2018

Ana Paula Candiota

0 references

Magdalena Ciezka

1 reference

14 February 2018

Milena Acosta

1 reference

14 February 2018

Cristina Herranz

1 reference

14 February 2018

Martí Pumarola

1 reference

14 February 2018

publication date

21 June 2016

1 reference

14 February 2018

Journal of Neuro-Oncology

published in

1 reference

14 February 2018

volume

129

1 reference

14 February 2018

issue

1 reference

14 February 2018

page(s)

67-76

1 reference

14 February 2018

The 2007 WHO classification of tumours of the central nervous system

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2164-3

CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2164-3

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2164-3

Treatment of malignant gliomas: radiotherapy, chemotherapy and integration of new targeted agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2164-3

Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2164-3

Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2164-3

mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2164-3

Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: correlation with histopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2164-3

Detailed characterization of the mouse glioma 261 tumor model for experimental glioblastoma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2164-3

Orthotopic transplantation of v-src-expressing glioma cell lines into immunocompetent mice: establishment of a new transplantable in vivo model for malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2164-3

A preclinical orthotopic model for glioblastoma recapitulates key features of human tumors and demonstrates sensitivity to a combination of MEK and PI3K pathway inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2164-3

MR imaging features of high-grade gliomas in murine models: how they compare with human disease, reflect tumor biology, and play a role in preclinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2164-3

21 January 2018

Glioblastoma in adults

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2164-3

Proton magnetic resonance spectroscopy ((1)H MRS) of human brain tumours: assessment of differences between tumour types and its applicability in brain tumour categorization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2164-3

The clinical value of proton magnetic resonance spectroscopy in adult brain tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2164-3

In vivo molecular imaging for planning radiation therapy of gliomas: an application of 1H MRSI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2164-3

Serial evaluation of patients with brain tumors using volume MRI and 3D 1H MRSI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2164-3

Dimethyl sulfoxide (DMSO) as a potential contrast agent for brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2164-3

Perturbation of mouse glioma MRS pattern by induced acute hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2164-3

1H-MRSI pattern perturbation in a mouse glioma: the effects of acute hyperglycemia and moderate hypothermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2164-3

Molecular imaging coupled to pattern recognition distinguishes response to temozolomide in preclinical glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2164-3

Implantation of GL261 neurospheres into C57/BL6 mice: a more reliable syngeneic graft model for research on glioma-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2164-3

Establishment and characterization of primary glioblastoma cell lines from fresh and frozen material: a detailed comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2164-3

Growth inhibition of newly established human glioma cell lines by leukemia inhibitory factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2164-3

Establishment of two glioma cell lines from two surgical specimens obtained at different times from the same individual

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2164-3

Cryopreservation of viable human glioblastoma xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2164-3

Primary glioma spheroids maintain tumourogenicity and essential phenotypic traits after cryopreservation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2164-3

Cryopreservation of neurospheres derived from human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2164-3

Multimodality Assessment of Brain Tumors and Tumor Recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-016-2164-3

Proton magnetic resonance spectroscopy imaging in the study of human brain cancer

21 January 2018

1 reference

12 December 2020

Development of an animal brain tumor model and its response to therapy with 1,3-bis(2-chloroethyl)-1-nitrosourea.

1 reference

12 December 2020

Genetic determinants of malignancy in a mouse model for oligodendroglioma

1 reference

12 December 2020

Cell culture in esophageal squamous cell carcinoma and the association with molecular markers.

1 reference

12 December 2020

Improving the classification of brain tumors in mice with perturbation enhanced (PE)-MRSI

1 reference

12 December 2020

10.1007/S11060-016-2164-3

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018